{
    "2018-10-22": [
        [
            {
                "time": "",
                "original_text": "看好中国｜看好中国——健康中国 关注错杀的绩优股",
                "features": {
                    "keywords": [
                        "健康中国",
                        "绩优股",
                        "错杀"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：注重创新与研发 荐5股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "创新",
                        "研发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【东北医药崔洁铭/齐震】智飞生物（300122）三季报点评：业绩持续高增长，重磅疫苗放量可期",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "三季报",
                        "高增长",
                        "重磅疫苗"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "44股获券商买入评级：中南建设目标涨幅达74%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "中南建设",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "房地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药|杜佐远团队太平洋证券】智飞生物(300122)：业绩符合预期，重磅在研品种值得期待",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩",
                        "预期",
                        "重磅在研品种"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报:政策底部明显,绩优股或反弹",
                "features": {
                    "keywords": [
                        "医药行业",
                        "政策底部",
                        "绩优股",
                        "反弹"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}